Endo Expands Voluntary Recall of Clonazepam Orally Disintegrating Tablets, USP (C-IV) Due to Potential Product Carton Strength Mislabeling
Endo, Inc. (OTCQX: NDOI) ("Endo") announced today that one of its operating subsidiaries, Endo USA, Inc., is expanding its ...
Endo USA Expands Recall Of Clonazepam Orally Disintegrating Tablets
Endo USA, Inc., affiliated to generics and specialty branded pharmaceutical company Endo, Inc., has expanded its recall of Clonazepam ...
Nasdaq7d
Endo USA Expands Recall Of Clonazepam Orally Disintegrating Tablets
(RTTNews) - Endo USA, Inc., affiliated to generics and specialty branded pharmaceutical company Endo, Inc., has expanded its recall of Clonazepam Orally Disintegrating Tablets (C-IV), according to ...
Morningstar8d
Endo Expands Voluntary Recall of Clonazepam Orally Disintegrating Tablets, USP (C-IV) Due to Potential Product Carton Strength Mislabeling
Clonazepam Orally Disintegrating Tablets are indicated alone or as an adjunct in the treatment of the Lennoz-Gastaut syndrome (petit mal variant), akinetic and myoclonic seizures. Additionally ...
KHON24d
Clonazepam tablets recalled over ‘life-threatening’ label mistake
The company that produces the tablets has said the medication is mislabeled with the incorrect strength on the carton.
Pharmabiz7d
Endo expands voluntary recall of clonazepam orally disintegrating tablets, USP due to potential product carton strength mislabelling
Malvern, Pennsylvania Wednesday, November 20, 2024, 11:00 Hrs [IST] ...
Monthly Prescribing Reference8d
More Clonazepam ODT Recalled Due to Carton Strength Mislabeling
Credit: Endo, Inc At this time, there have been no reports of adverse events related to this recall. While the blister strips within the cartons reflect the correct strength and lot number, the ...